Learn more about rebound hyperbilirubinemia in newborns, including its causes, symptoms and treatment options.

Learn more about haptoglobin, including what it is, how it works and why infants with HDFN often have low haptoglobin levels.

A recent study found that an anti-Kell antibody level of eight can be used to reliably identify patients at risk of severe ...

Nipocalimab, an emerging therapeutic agent for hemolytic disease of the fetus and newborn (HDFN), does not appear to affect ...

The FDA approved Johnson & Johnson’s nipocalimab, which is also being studied as a potential treatment in HDFN, in myasthenia ...